Procainamide nonclinical toxicology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
ShiSheng (talk | contribs)
nocaptcha
8,707 edits
Created page with "__NOTOC__ {{Procainamide}} {{CMG}}; {{AE}} {{SS}} ==Nonclinical Toxicology== ===Teratogenic Effects: Pregnancy Category C=== Animal reproduction studies have not been cond..."
 
GeraldChi (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
8,887 edits
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Procainamide#Nonclinical Toxicology]]
{{Procainamide}}
{{CMG}}; {{AE}} {{SS}}
 
==Nonclinical Toxicology==
 
 
===Teratogenic Effects: Pregnancy Category C===
 
Animal reproduction studies have not been conducted with PA. It also is not known whether PA can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. PA should be given to a pregnant woman only if clearly needed.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PROCAINAMIDE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17e47845-daad-434c-a784-6d3875b0d704 | publisher =  | date =  | accessdate = 11 March 2014 }}</ref>
==References==
{{Reflist}}
 
[[Category:Benzamides]]
[[Category:Anilines]]
[[Category:Sodium channel blockers]]
[[Category:Antiarrhythmic agents]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 21:58, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Procainamide_nonclinical_toxicology&oldid=997374"